Reilly Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$128K Buy
987
+30
+3% +$3.5K 0.01% 251
2021
Q3
$108K Hold
957
0.01% 257
2021
Q2
$99K Hold
957
0.01% 275
2021
Q1
$80K Hold
957
0.01% 290
2020
Q4
$87K Buy
957
+39
+4% +$3.23K 0.01% 267
2020
Q3
$73K Sell
918
-60
-6% -$4.68K 0.01% 260
2020
Q2
$68K Hold
978
0.01% 271
2020
Q1
$61K Buy
978
+60
+7% +$4.33K 0.01% 263
2019
Q4
$71K Hold
918
0.01% 287
2019
Q3
$67K Hold
918
0.01% 303
2019
Q2
$57K Hold
918
0.01% 340
2019
Q1
$59K Hold
918
0.01% 322
2018
Q4
$47K Sell
918
-120
-12% -$6.07K 0.01% 344
2018
Q3
$60K Hold
1,038
0.01% 330
2018
Q2
$50K Hold
1,038
0.01% 315
2018
Q1
$48K Buy
1,038
+543
+110% +$23.6K 0.01% 307
2017
Q4
$19K Sell
495
-300
-38% -$11K ﹤0.01% 523
2017
Q3
$29K Hold
795
﹤0.01% 403
2017
Q2
$31K Sell
795
-390
-33% -$14.2K ﹤0.01% 395
2017
Q1
$37K Sell
1,185
-5,835
-83% -$183K 0.01% 346
2016
Q4
$219K Sell
7,020
-248,820
-97% -$8.06M 0.04% 142
2016
Q3
$10.3M Buy
255,840
+120
+0% +$4.52K 1.82% 21
2016
Q2
$8.5M Sell
255,720
-14,187
-5% -$485K 1.56% 30
2016
Q1
$7.94M Buy
269,907
+7,515
+3% +$207K 1.36% 34
2015
Q4
$6.91M Buy
+262,392
New +$6.81M 1.22% 42

Other funds holding EW

Reilly Financial Advisors's EW Position: Q4 2021 in Review

Reilly Financial Advisors increased its Edwards Lifesciences (EW) stake by 3.1% in Q4 2021, buying an estimated $3.5K and bringing the position to 987 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #251.

Reilly Financial Advisors first reported a position in EW in Q4 2015 and has held it in 25 quarters since. The position peaked at $10.3M in Q3 2016. 1,321 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • Reilly Financial Advisors held 987 shares of Edwards Lifesciences worth $128K as of Q4 2021.
  • Reilly Financial Advisors bought 30 Edwards Lifesciences shares in Q4 2021, an estimated $3.5K.
  • Edwards Lifesciences made up 0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #251 holding.
  • Reilly Financial Advisors first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 25 quarters since.
  • Reilly Financial Advisors's Edwards Lifesciences position peaked at $10.3M in Q3 2016.
  • 1,321 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.